Prevalence of the p.v600e variant in patients with colorectal cancer from Mexico and its estimated frequency in Latin American and Caribbean populations.
Clicks: 370
ID: 100546
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
66.4
/100
370 views
249 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #1 of 2 articles by views in journal of investigative medicine : the official publication of the american federation for clinical research
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
This study aimed to investigate the frequency of the somatic p.V600E in patients with colorectal cancer (CRC) in Mexico and compare it with those estimated for Latin American and Caribbean populations. One hundred and one patients with CRC with AJCC stages ranging I-IV from Western Mexico were included, out of which 55% were male and 61% had AJCC stage III-IV, with a mean age of 60 years. PCR-Sanger sequencing was used to identify the BRAF p.V600E variant. In addition, a systematic literature search in PubMed/Medline database and Google of the 42 countries in Latin America and the Caribbean led to the collection of information on the p.V600E variant frequency of 17 population reports. To compare the variant prevalence among populations, a statistical analysis was performed using GraphPad Prism V.6.0. We found that 4% of patients with CRC were heterozygous for the p.V600E variant. The χ test showed no significant difference (p>0.05) in p.V600E detection when comparing with other Latin American and Caribbean CRC populations, except for Chilean patients (p=0.02). Our observational study provides the first evidence on the frequency of p.V600E in patients with CRC from Western Mexico, which is 4%, but increases to 7.8% for all of Latin America and the Caribbean. The patient mean age and genetic descent on the observed frequencies of the variant in populations could influence the frequency differences.
| Reference Key |
hernndezsandoval2020prevalencejournal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Hernández-Sandoval, Jesús Arturo;Gutiérrez-Angulo, Melva;Magaña-Torres, María Teresa;Alvizo-Rodríguez, Carlos Rogelio;Ramírez-Plascencia, Helen Haydee Fernanda;Flores-López, Beatriz Armida;Valenzuela-Pérez, Jesús Alonso;Peregrina-Sandoval, Jorge;Moreno-Ortiz, José Miguel;Domínguez-Valentín, Mev;Ayala-Madrigal, María de la Luz; |
| Journal | journal of investigative medicine : the official publication of the american federation for clinical research |
| Year | 2020 |
| DOI |
jim-2020-001301
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.